TruBridge, Inc. (TBRG)
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
$26.240.00%
Close 2026-07-10 · 1-day change
NASDAQHealth CareMedical - Healthcare Information ServicesSnapshot 2026-09-04
QuarterlyIQ Insights · TBRG
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-09-06. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $26 TBRG trades at 10× p/e, below its 20× p/e peer median. Our $44 fair value sits well above the price. We hold it with low confidence: our number sits well above the analyst range and the peer anchor overstates how cheap it looks. Analysts target $26–$26. Note: our $44 fair value sits above the entire analyst range ($26–$26). Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $26.25 | — | — | Analyst | high |
| dcf fcfe | 12M | $135.31 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $202.80 | — | — | Hist. CAGR | high |
| graham number | 12M | $26.79 | — | — | TTM | high |
| Peer P/FCF | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
$26.25 – $26.25 (median $26.25) · 3 analysts · as of 2026-04-27
No fragility gates fired. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Not enough peers to compare yet.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $39.46 |
| 13.7 |
| 2.87 |
| TTM |
| high |
| Peer P/E | 12M | $53.30 | 20.5 | 2.60 | TTM | high |
| Peer P/S | 12M | $40.94 | 1.7 | 23.75 | TTM | high |
| PEG | 12M | $23.59 | 9.1 | 2.60 | TTM | high |
| residual income | 12M | $18.99 | — | — | TTM | high |
| Own P/E history | 12M | $26.20 | 10.1 | 2.60 | TTM | high |
| triangulated | 12M | $56.71 | 20.5 | 2.77 | Triangulated | high |
| Peer P/FCF | 3Y | $60.01 | 13.7 | 4.37 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $60.78 | 20.5 | 2.96 | Analyst | medium |
| Peer P/S | 3Y | $43.88 | 1.7 | 25.45 | guidance | medium |
| PEG | 3Y | $26.90 | 9.1 | 2.96 | Analyst | medium |
| Own P/E history | 3Y | $29.88 | 10.1 | 2.96 | Analyst | medium |
| Peer P/FCF | 5Y | $79.37 | 13.7 | 5.78 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $60.99 | 20.5 | 2.98 | Analyst | high |
| Peer P/S | 5Y | $44.03 | 1.7 | 25.54 | guidance | high |
| PEG | 5Y | $26.99 | 9.1 | 2.98 | Analyst | high |
| Own P/E history | 5Y | $29.98 | 10.1 | 2.98 | Analyst | high |